Please use this identifier to cite or link to this item: https://doi.org/10.1002/biot.202000013
Title: Engineering the Gut Microbiome for Treatment of Obesity: A Review of Current Understanding and Progress
Authors: Lim, Yvonne Yijuan 
Lee, Yung Seng 
Ooi, Delicia Shu Qin 
Keywords: Science & Technology
Life Sciences & Biomedicine
Biochemical Research Methods
Biotechnology & Applied Microbiology
Biochemistry & Molecular Biology
bioengineering
microbiome
obesity
synthetic biology
translational medicine
LACTOBACILLUS-GASSERI BNR17
DIET-INDUCED OBESITY
HIGH-FAT DIET
WEIGHT-LOSS
ANTIBIOTIC EXPOSURE
CESAREAN-SECTION
DOUBLE-BLIND
OVERWEIGHT
TERM
ALTERS
Issue Date: 2020
Publisher: WILEY-V C H VERLAG GMBH
Citation: Lim, Yvonne Yijuan, Lee, Yung Seng, Ooi, Delicia Shu Qin (2020). Engineering the Gut Microbiome for Treatment of Obesity: A Review of Current Understanding and Progress. BIOTECHNOLOGY JOURNAL 15 (10). ScholarBank@NUS Repository. https://doi.org/10.1002/biot.202000013
Abstract: © 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim Obesity is a complex, multifactorial disease that is increasing in prevalence despite extensive research and efforts to curb it. Over the last decade, gut microbiome has emerged as an important contributor to the pathogenesis of obesity. Microbiome profile is altered in obese phenotype and the causative role of microbiome in obesity is demonstrated in fecal microbiota transplantation studies. Herein, recent evidences supporting the role of gut microbiome in obesity and the current therapies designed to engineer gut microbiome for treatment of obesity will be reviewed. The microbial enterotypes associated with obesity is outlined, and the gut microbiota-driven metabolism and low-grade inflammation linking gut microbiome and obesity is examined. How the different intrinsic and extrinsic factors such as host genetics, mode of childbirth delivery, diet, lifestyle habits and use of antibiotics influence the composition of the gut microbiome in the development of obesity is evaluated. Also, the efficacy of current microbiome-based therapies in the forms of prebiotics, probiotics and engineered microbes that are used to manipulate gut microbiome in treating obesity is discussed.
Source Title: BIOTECHNOLOGY JOURNAL
URI: https://scholarbank.nus.edu.sg/handle/10635/177213
ISSN: 18606768
18607314
DOI: 10.1002/biot.202000013
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Engineering the gut microbiome for treatment of obesity.docx605.18 kBMicrosoft Word XML

OPEN

Post-printView/Download

SCOPUSTM   
Citations

7
checked on May 11, 2022

Page view(s)

247
checked on May 12, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.